Dolasetron. A new 5-hydroxytryptamine3 receptor antagonist.
Hui
Y F
YF
University of California, San Francisco, USA.
Ignoffo
R J
RJ
D000932:Antiemetics / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D011807:Quinolizines / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D000932:Antiemetics; D007211:Indoles; D011807:Quinolizines; D012702:Serotonin Antagonists; C060344:dolasetron